Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mo Yang

Showing results (1531-1540 of 1,672) with videos related to

Pageof 168
Sort By:
Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.
Thrombosis and Haemostasis|March 14, 2018
Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre StudyJeehoon Kang, Jung-Kyu Han, Youngkeun Ahn, et al.
American Heart Journal|January 29, 2013
Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trialsKyung Woo Park, Si-Hyuck Kang, Matthijs A Velders, et al.
The Journal of Biological Chemistry|August 2, 2025
Discovery of thiacyanine dyes as a new class of potent coronavirus inhibitors that suppress viral RNA synthesisTianyi Zhang, Valerie Altouma, Joshua A Sommers, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 18, 2024
Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT TrialJeehoon Kang, Doyeon Hwang, Kyung Woo Park, et al.
Journal of Gastroenterology and Hepatology|May 1, 2024
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis BHeechul Nam, Ji Won Han, Soon Kyu Lee, et al.
Heart (British Cardiac Society)|February 25, 2011
Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trialKyung Woo Park, Jin Joo Park, Seung-Pyo Lee, et al.
Science (New York, N.Y.)|May 2, 2024
N-type semiconducting hydrogelPeiyun Li, Wenxi Sun, Jiulong Li, et al.
Journal of Clinical Medicine|February 11, 2023
Can Measuring the 'Dual Anchors of Aorta' Enhance the Success Rate of TAVR?-A Single-Center ExperienceYang Chen, Md Misbahul Ferdous, Lakshme Kottu, et al.
Nature|May 14, 2025
Unconventional domain tessellations in moiré-of-moiré latticesDaesung Park, Changwon Park, Kunihiro Yananose, et al.
Pageof 168

Showing results (1531-1540 of 1,672) with videos related to

Sort By:
Pageof 168
Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.
Thrombosis and Haemostasis|March 14, 2018
Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre StudyJeehoon Kang, Jung-Kyu Han, Youngkeun Ahn, et al.
American Heart Journal|January 29, 2013
Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trialsKyung Woo Park, Si-Hyuck Kang, Matthijs A Velders, et al.
The Journal of Biological Chemistry|August 2, 2025
Discovery of thiacyanine dyes as a new class of potent coronavirus inhibitors that suppress viral RNA synthesisTianyi Zhang, Valerie Altouma, Joshua A Sommers, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 18, 2024
Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT TrialJeehoon Kang, Doyeon Hwang, Kyung Woo Park, et al.
Journal of Gastroenterology and Hepatology|May 1, 2024
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis BHeechul Nam, Ji Won Han, Soon Kyu Lee, et al.
Heart (British Cardiac Society)|February 25, 2011
Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trialKyung Woo Park, Jin Joo Park, Seung-Pyo Lee, et al.
Science (New York, N.Y.)|May 2, 2024
N-type semiconducting hydrogelPeiyun Li, Wenxi Sun, Jiulong Li, et al.
Journal of Clinical Medicine|February 11, 2023
Can Measuring the 'Dual Anchors of Aorta' Enhance the Success Rate of TAVR?-A Single-Center ExperienceYang Chen, Md Misbahul Ferdous, Lakshme Kottu, et al.
Nature|May 14, 2025
Unconventional domain tessellations in moiré-of-moiré latticesDaesung Park, Changwon Park, Kunihiro Yananose, et al.
Pageof 168